GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $489,000 | -23.7% | 11,231 | -23.7% | 0.05% | +160.0% |
Q1 2022 | $641,000 | -1.7% | 14,714 | -0.5% | 0.02% | +5.3% |
Q4 2021 | $652,000 | -69.2% | 14,786 | -73.4% | 0.02% | -38.7% |
Q3 2021 | $2,120,000 | -4.2% | 55,496 | -0.2% | 0.03% | -31.1% |
Q2 2021 | $2,214,000 | +12.8% | 55,596 | +1.1% | 0.04% | -4.3% |
Q1 2021 | $1,963,000 | -2.6% | 55,001 | +0.5% | 0.05% | -9.6% |
Q4 2020 | $2,015,000 | +0.0% | 54,747 | +2.3% | 0.05% | -16.1% |
Q3 2020 | $2,014,000 | -7.7% | 53,520 | 0.0% | 0.06% | -8.8% |
Q2 2020 | $2,183,000 | -29.9% | 53,520 | -34.9% | 0.07% | +23.6% |
Q1 2020 | $3,114,000 | +61.3% | 82,188 | +100.0% | 0.06% | +7.8% |
Q4 2019 | $1,931,000 | +10.1% | 41,094 | 0.0% | 0.05% | +4.1% |
Q3 2019 | $1,754,000 | +27.8% | 41,094 | +19.9% | 0.05% | +25.6% |
Q2 2019 | $1,372,000 | -4.2% | 34,274 | 0.0% | 0.04% | 0.0% |
Q1 2019 | $1,432,000 | +9.9% | 34,274 | +0.5% | 0.04% | +5.4% |
Q4 2018 | $1,303,000 | -3.5% | 34,108 | +1.5% | 0.04% | +8.8% |
Q3 2018 | $1,350,000 | – | 33,600 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |